Every article, report, and earnings note where COR appears.
Cencora, Inc. (COR) posted a clean earnings beat, with EPS and revenue topping estimates and shares gaining 3.41%. This deep-dive examines segment performance, margin drivers, updated guidance, and what the result says about the company’s operating momentum and valuation backdrop.
Cencora, Inc. (COR) gains 3.2% after posting earnings beats, lifting shares as investors react to stronger-than-expected quarterly results.
Cencora posted 7.5% adjusted EPS growth in Q2 and raised full-year guidance, with specialty pharmaceuticals and international healthcare driving the upside. Thin margins and higher debt keep the story balanced, but the stock still screens as a Buy.
Three data center REIT picks ranked by investment quality — Digital Realty takes No. 2, while the No. 1 spot is revealed at the end of the countdown.
Cencora, Inc. (COR) slumps after missing on EPS and revenue, but the full story goes beyond the headline. This deep-dive unpacks U.S. Healthcare Solutions pressure, international strength, margin shifts, and why raised EPS guidance couldn’t offset a revenue reset.
Cencora, Inc. (COR) slumps after a mixed fiscal Q2 2026 report. Revenue rose and full-year guidance increased, but adjusted EPS missed expectations, sparking heavy selling as investors reassess the stock’s premium valuation and execution outlook.
Cencora, Inc. (COR) slumps 17.4% after reporting earnings misses, as investors react to weaker-than-expected results and pressure on the stock.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate COR ReportCancel anytime